Articles From: Esperion Therapeutics to Host Conference Call on September 3, 2013 to Announce Top-line Results from a Phase 2 Clinical Study of ETC-1002 as an Add-On to Statin Therapy in Patients with Hypercholesterolemia to ESSA Bancorp, Inc. Declares Quarterly Dividend


2013/8/30
Esperion Therapeutics, Inc. (Nasdaq:ESPR) , a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that it will host a conference call and webcast on Tuesday, September 3, 2013 at 8:30 a.m. Eastern Time (ET) to present top-line results from a Phase 2a clinical study of its lead product candidate, ETC-1002, as an add-on to statin therapy in patients with hypercholesterolemia.
Sign-up for Esperion Therapeutics to Host Conference Call on September 3, 2013 to Announce Top-line Results from a Phase 2 Clinical Study of ETC-1002 as an Add-On to Statin Therapy in Patients with Hypercholesterolemia investment picks
2014/3/24
Esperion Therapeutics, Inc. (NASDAQ: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that Tim M.
Sign-up for Esperion Therapeutics to Present at BioCentury Future Leaders in the Biotech Industry Conference investment picks
2013/9/24
Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that Tim M.
Sign-up for Esperion Therapeutics to Present at BioCentury Newsmakers in the Biotech Industry Conference investment picks
Esperion Therapeutics, Inc. (NASDAQ: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that Tim M.
Sign-up for Esperion Therapeutics to Present at Credit Suisse Healthcare Conference investment picks
2013/9/10
Esperion Therapeutics, Inc. (Nasdaq: ESPR) , a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that Roger S.
Sign-up for Esperion Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference investment picks
2014/2/26
Esperion Therapeutics, Inc. (NASDAQ:ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that it will host a conference call and webcast to provide program development updates and discuss financial results for the fourth quarter and full year ended Dec.
Sign-up for Esperion Therapeutics to Provide ETC-1002 Program Update; Fourth Quarter and Full Year 2013 Financial Results investment picks
Espial Brings HTML5 User Experience for RDK IP Set-Top Boxes at RDK User Conference Canada NewsWire OTTAWA , Feb.
Sign-up for Espial Brings HTML5 User Experience for RDK IP Set-Top Boxes at RDK User Conference investment picks
Espial Introduces New Version of Espial TV Browser Canada NewsWire Leveraging HTML5, HbbTV, WebKit, and Advanced Chipset Capabilities, Espial TV Browser Enhances the Smart TV and Set-Top Box Experience OTTAWA , Aug.
Sign-up for Espial Introduces New Version of Espial TV Browser investment picks
2014/2/18
Espial Invited to Showcase HTML5 User Experience in the W3C Booth at Mobile World Congress Canada NewsWire OTTAWA , Feb.
Sign-up for Espial Invited to Showcase HTML5 User Experience in the W3C Booth at Mobile World Congress investment picks
2014/3/18
Espial Joins RDK Panel at TV Connect 2014 Canada NewsWire OTTAWA , March 18, 2014 /CNW/ - Espial, a leader in on-demand TV software and solutions, today announced that Jaison Dolvane, the company's President and CEO, will join executives from Liberty Global, RDK LLC, and Zon on a panel discussion about the global impact of the RDK during TV Connect 2014 entitled, RDK: Moving the Television Experience Forward at Warp Speed on March 18 th at 16:50 pm GMT in London .
Sign-up for Espial Joins RDK Panel at TV Connect 2014 investment picks
Espial Reports 2013 Third Quarter Results Canada NewsWire OTTAWA , Oct.
Sign-up for Espial Reports 2013 Third Quarter Results investment picks
2014/2/26
Espial Reports Fourth Quarter Results Canada NewsWire "We had a strong Q4 and a good finish to 2013.
Sign-up for Espial Reports Fourth Quarter Results investment picks
2013/10/16
Espial Signs Major Contract with Tier 1 North American Cable Operator Canada NewsWire Espial RDK Set-top Box Solutions & Espial G4 User Experience to Power N-Next Generation of Set-top Boxes and wireless devices OTTAWA , Oct.
Sign-up for Espial Signs Major Contract with Tier 1 North American Cable Operator investment picks
2014/3/26
Espial Talks RDK at Light Reading Event Canada NewsWire OTTAWA , March 26, 2014 /CNW/ - Espial, a leader in on-demand TV software and solutions, today announced that the company's President and CEO, Jaison Dolvane will join executives from Cox and Time Warner Cable at Light Reading's Cable Next-Gen Technologies & Strategies Event on the panel, The RDK Revolution on March 27 th at 3:40 pm MDT in Denver .
Sign-up for Espial Talks RDK at Light Reading Event investment picks
2014/2/24
Espial® Group Inc. - 2013 Fourth Quarter and Fiscal Year Financial Results Call and Dial-In Information Canada NewsWire About Espial ( www.espial.com ) Espial is a leading supplier of digital TV and IPTV software and solutions to cable MSOs and telecommunications operators as well as consumer electronics manufacturers.
Sign-up for Espial® Group Inc. - 2013 Fourth Quarter and Fiscal Year Financial Results Call and Dial-In Information investment picks
2014/1/16
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has raised its offer to acquire all outstanding shares of Archon Corporation to a price of $19.25 per share in a negotiated transaction, subject to confirmatory due diligence.
Sign-up for Esplanade Capital Raises Offer For Archon Corporation to $19.25 per Share investment picks
2013/10/9
AOL Inc. (NYSE:AOL) and ESPN today announced they have reached an agreement that provides AOL’s audience access to a majority of video from ESPN, including news, highlights and analysis.
Sign-up for ESPN and AOL Strike Premium Video Syndication Agreement investment picks
2014/4/1
In the weeks immediately following the announcement of their groundbreaking, multi-year distribution deal , DISH Network Corporation (NASDAQ:DISH) and The Walt Disney Company (NYSE:DIS) today announced the availability of WATCH ABC, WATCH ABC Family, WATCH Disney Channel, WATCH Disney XD and WatchESPN, enabling DISH’s 14 million video subscribers to access live and on-demand news, entertainment and sports programming on computers, smartphones, tablets, gaming consoles and connected devices.
Sign-up for ESPN and Disney/ABC Television Group Launch WATCH Authenticated Products to DISH Customers investment picks
ESPN’s Customer Marketing and Sales announces that ESPN will join the MAGNA Consortium, a group dedicated to using data and technology to unlock the true power of all media.
Sign-up for ESPN Joins IPG Mediabrands’ MAGNA CONSORTIUM investment picks
2013/10/3
By Michael Calia ESPN said Thursday that it no longer would hold events for its extreme-sports brand in four international locations, saying the future doesn't look economically sustainable for them.
Sign-up for ESPN to Cease X Games Events Outside the U.S. investment picks
2014/2/18
DALLAS , Feb.
Sign-up for Esposito Global Announces Proposal to acquire SWS Group, Inc. (NYSE: SWS) at $8.00 a Share in Cash investment picks
2014/1/24
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1084473&ProfileId=051205&sourceType=1 STROUDSBURG, PA --
Sign-up for ESSA Bancorp Acquires a Monroe County, PA. Branch Facility, Deposits and Loans investment picks
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1043710&ProfileId=051205&sourceType=1 STROUDSBURG, PA --
Sign-up for ESSA Bancorp Announces Monroe County, Pa. Branch Facility Acquisition, Deposit and Loan Assumption investment picks
2014/4/4
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104046&ProfileId=051205&sourceType=1 STROUDSBURG, PA and WILKES-BARRE, PA --
Sign-up for ESSA Bancorp, Inc. Announces Completion of Franklin Security Bancorp Acquisition investment picks
2014/1/29
ESSA Bancorp, Inc. (NASDAQ Global Market SM : ESSA), the holding Company for ESSA Bank & Trust, a $1.4 billion asset institution providing full service retail and commercial banking, financial and investment services, today announced results for fiscal first quarter, 2014.
Sign-up for ESSA Bancorp, Inc. Announces Fiscal First Quarter 2014 Financial Results investment picks
2013/10/23
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1061990&ProfileId=051205&sourceType=1 STROUDSBURG, PA --
Sign-up for ESSA Bancorp, Inc. Announces Fiscal Fourth Quarter Earnings Results and Record Net Income for 2013 investment picks
2013/9/3
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1047268&ProfileId=051205&sourceType=1 STROUDSBURG, PA --
Sign-up for ESSA Bancorp, Inc. Declares Quarterly Dividend investment picks
http://media.marketwire.com/attachments/201203/41373_essa.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1071175&ProfileId=051205&sourceType=1 STROUDSBURG, PA --
Sign-up for ESSA Bancorp, Inc. Declares Quarterly Dividend investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Esperion Therapeutics to Host Conference Call on September 3, 2013 to Announce Top-line Results from a Phase 2 Clinical Study of ETC-1002 as an Add-On to Statin Therapy in Patients with Hypercholesterolemia to ESSA Bancorp, Inc. Declares Quarterly Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity